Bloomberg ·

Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a valuation of at least $40B

Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.'s Google DeepMind, is in early talks to raise new funds …

Google AI Venture Capital

In this story Google DeepMind Isomorphic Labs

Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a valuation of at least $40B

Lead Source

Bloomberg — Isomorphic Labs, an AI drug discovery startup spun out of Google DeepMind, is in early talks to raise funds at a valuation of at least $40B ↗

How this story grew

Coverage · 0 Discussion · 0

Oct 8Oct 9

More

Proactive: Proactive

Discussion

Related stories

Financial Times: Emulate, a month-old UK AI startup founded by former Google DeepMind researchers, is in advanced talks to raise as much as $700M at a $3.7B valuation

Bloomberg: AI coding startup Cognition is in early talks with investors to raise $1B+ at a $40B+ valuation, after raising $1B at a $26B valuation in May

Forbes: Albert Invent, which launched an AI model trained on chemical patents and data about 15M molecules, raised a $55M Series B, a source says at a $340M valuation

Reuters: Shanghai-based Anew Labs, a ByteDance spinoff using AI for drug discovery, raised $290M from HSG, IDG Capital, and others at a $1.5B valuation

Reuters: Meta, Google DeepMind, and Isomorphic Labs invest $300M and the US invests $500M+ in Zuckerberg-backed Biohub to build open biology datasets for AI training

Discuss with AI

ChatGPT ↗ Claude ↗

← Back to TechSnif